Pulsenmore Ltd
TASE:PULS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Pulsenmore Ltd
Total Liabilities & Equity
Pulsenmore Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pulsenmore Ltd
TASE:PULS
|
Total Liabilities & Equity
₪141.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
88%
|
CAGR 10-Years
N/A
|
|
|
B
|
Brainsway Ltd
TASE:BWAY
|
Total Liabilities & Equity
$113.1m
|
CAGR 3-Years
19%
|
CAGR 5-Years
27%
|
CAGR 10-Years
17%
|
|
|
Inmode Ltd
NASDAQ:INMD
|
Total Liabilities & Equity
$766.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Sisram Medical Ltd
HKEX:1696
|
Total Liabilities & Equity
$657.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
Total Liabilities & Equity
$105.7m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sofwave Medical Ltd
TASE:SOFW
|
Total Liabilities & Equity
$55.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
Pulsenmore Ltd
Glance View
PulseNmore Ltd. engages in research and development, production, marketing, and sales worldwide of technological solutions that involve portable ultrasound devices for home use by the patient for remote physical examination or monitoring using telehealth technology. The firm engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products.
See Also
What is Pulsenmore Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
141.8m
ILS
Based on the financial report for Dec 31, 2024, Pulsenmore Ltd's Total Liabilities & Equity amounts to 141.8m ILS.
What is Pulsenmore Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
88%
Over the last year, the Total Liabilities & Equity growth was -21%. The average annual Total Liabilities & Equity growth rates for Pulsenmore Ltd have been -5% over the past three years , 88% over the past five years .
